SSRIs and SNRIs: risk of persistent pulmonary hypertension in the newborn
May 16 2010 at 9:16 AM Anonymous
Response to risk of PPH raises 2.5 times
--------------------------------------------------------------------------------
Drug safety advice
SSRIs and SNRIs: risk of persistent pulmonary hypertension in the newborn
Antidepressants: risk of fractures
Carbapenems: concomitant use with valproic acid not recommended
Oral tacrolimus products: measures to reduce the risk of medication errors
Simvastatin: increased risk of myopathy at high dose (80 mg)
Stop press
Panitumumab (Vectibix): serious hypersensitivity reactions
Other information from the MHRA
Patient information leaflet of the month: Durogesic DTrans Transdermal Patch
Download documents:
Drug Safety Update: Volume 3, Issue 10, May 2010 (106Kb)
Seroxat is also known as Paxil and Aropax. Blog exposes Bob Fiddaman Human rights abuser who won two SCIENTOLOGY CCHR (human rights!) awards.
blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1
This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1
Sunday 16 May 2010
SSRIs and SNRIs: risk of persistent pulmonary hypertension in the newborn - MHRA safety warning
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.